The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

Phase: PHASE2 | Sponsor: Joshua Woolley, MD, PhD | Compound: Psilocybin

Status

recruiting

Institution

Joshua Woolley, MD, PhD

Start date

2024-08-19

End date

2028-06-01

Registry ID

NCT06455293

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.